• Home
  • GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.

GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.

Author List
Kuang R, Jahangiri A, Mascharak S, Nguyen A, Chandra A, Flanigan PM, Yagnik G, Wagner JR, De Lay M, Carrera D, Castro BA, Hayes J, Sidorov M, Garcia JLI, Eriksson P, Ronen S, Phillips J, Molinaro A, Koliwad S, Aghi MK
Publication
JCI insight
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1208223
Publication Year
2017
PubMed ID
28138554
Publication Title
Kuang R, Jahangiri A, Mascharak S, Nguyen A, Chandra A, Flanigan PM, Yagnik G, Wagner JR, De Lay M, Carrera D, Castro BA, Hayes J, Sidorov M, Garcia JLI, Eriksson P, Ronen S, Phillips J, Molinaro A, Koliwad S, Aghi MK. GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance. JCI Insight. 2017 01 26; 2(2):e88815.